INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GRAIL, Inc. of Class Action Lawsuit and Upcoming Deadlines – GRAL

Pomerantz LLP announces that a class action lawsuit has been filed against GRAIL, Inc. (“Grail” or the “Company”) (NASDAQ: GRAL). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.

The class action concerns whether Grail and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. You have until August 4, 2026, to ask the Court to appoint you as Lead Plaintiff for the class if you purchased or otherwise acquired Grail securities during the Class Period. A copy of the Complaint can be obtained at www.pomerantzlaw.com.

On February 19, 2026, Grail announced that “primary endpoint of statistically significant Stage III-IV reduction was not observed” in the NHS-Galleri Trial. Grail attributed this shortcoming, in part, to “probably need[ing] a longer follow-up time to be able to [compare the study arms] adequately.” On this news, Grail’s stock price fell more than 50%, damaging investors.